213 related articles for article (PubMed ID: 11952539)
21. Dysregulation of Telomere Lengths and Telomerase Activity in Myelodysplastic Syndrome.
Park HS; Choi J; See CJ; Kim JA; Park SN; Im K; Kim SM; Lee DS; Hwang SM
Ann Lab Med; 2017 May; 37(3):195-203. PubMed ID: 28224765
[TBL] [Abstract][Full Text] [Related]
22. In-situ hybridization-based quantification of hTR: a possible biomarker in malignant melanoma.
Vagner J; Steiniche T; Stougaard M
Histopathology; 2015 Apr; 66(5):747-51. PubMed ID: 25601620
[TBL] [Abstract][Full Text] [Related]
23. Measurement of telomere length on tissue sections using quantitative fluorescence in situ hybridization (Q-FISH).
Ferlicot S; Youssef N; Feneux D; Delhommeau F; Paradis V; Bedossa P
J Pathol; 2003 Aug; 200(5):661-6. PubMed ID: 12898604
[TBL] [Abstract][Full Text] [Related]
24. Diagnosis of cutaneous melanocytic tumours by four-colour fluorescence in situ hybridisation.
Morey AL; Murali R; McCarthy SW; Mann GJ; Scolyer RA
Pathology; 2009; 41(4):383-7. PubMed ID: 19404853
[TBL] [Abstract][Full Text] [Related]
25. Presence of cytogenetic abnormalities in Spitz naevi: a diagnostic challenge for fluorescence in-situ hybridization analysis.
Martin V; Banfi S; Bordoni A; Leoni-Parvex S; Mazzucchelli L
Histopathology; 2012 Jan; 60(2):336-46. PubMed ID: 22211292
[TBL] [Abstract][Full Text] [Related]
26. Multiparametric image cytometry of nevi and melanomas.
Fleming MG; Friedman RJ
Am J Dermatopathol; 1993 Apr; 15(2):106-13. PubMed ID: 8494109
[TBL] [Abstract][Full Text] [Related]
27. Distribution and colocalization of markers for proliferation, invasion, motility and neoangiogenesis in benign melanocytic naevi and malignant melanomas.
Fröhlich E; Mack AF; Garbe C; Klessen C
Br J Dermatol; 2005 Dec; 153(6):1159-65. PubMed ID: 16307652
[TBL] [Abstract][Full Text] [Related]
28. Matrix metalloproteinase-2 (72 kD type IV collagenase) expression occurs in the early stage of human melanocytic tumour progression and may have prognostic value.
Väisänen A; Tuominen H; Kallioinen M; Turpeenniemi-Hujanen T
J Pathol; 1996 Nov; 180(3):283-9. PubMed ID: 8958806
[TBL] [Abstract][Full Text] [Related]
29. Discriminant analysis of image karyometric variables in benign and malignant melanocytic skin lesions.
Mijovic Z; Mihailovic D
Anal Quant Cytol Histol; 2002 Dec; 24(6):314-6. PubMed ID: 12508688
[TBL] [Abstract][Full Text] [Related]
30. Expression of matrilysin (matrix metalloproteinase-7) in primary cutaneous and metastatic melanoma.
Kawasaki K; Kawakami T; Watabe H; Itoh F; Mizoguchi M; Soma Y
Br J Dermatol; 2007 Apr; 156(4):613-9. PubMed ID: 17493064
[TBL] [Abstract][Full Text] [Related]
31. Fluorescence in situ hybridization (FISH) evaluation of chromosomes 6, 7, 9 and 10 throughout human melanocytic tumorigenesis.
Casorzo L; Luzzi C; Nardacchione A; Picciotto F; Pisacane A; Risio M
Melanoma Res; 2005 Jun; 15(3):155-60. PubMed ID: 15917696
[TBL] [Abstract][Full Text] [Related]
32. Loss of p16 expression and copy number changes of CDKN2A in a spectrum of spitzoid melanocytic lesions.
Harms PW; Hocker TL; Zhao L; Chan MP; Andea AA; Wang M; Harms KL; Wang ML; Carskadon S; Palanisamy N; Fullen DR
Hum Pathol; 2016 Dec; 58():152-160. PubMed ID: 27569296
[TBL] [Abstract][Full Text] [Related]
33. Telomerase activity in prognostic histopathologic features of melanoma.
Carvalho L; Lipay M; Belfort F; Santos I; Andrade J; Haddad A; Brunstein F; Ferreira L
J Plast Reconstr Aesthet Surg; 2006; 59(9):961-8. PubMed ID: 16920589
[TBL] [Abstract][Full Text] [Related]
34. Nuclear parameters in the superficial and deep portion of melanocytic lesions--a morphometrical investigation.
Smolle J; Soyer HP; Juettner FM; Hoedl S; Kerl H
Pathol Res Pract; 1988 Jun; 183(3):266-70. PubMed ID: 3420029
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melanocytic lesions of the skin using video imaging.
Pilch H; Günzel S; Schäffer U; Tanner B; Heine M
Cancer; 2000 Mar; 88(6):1370-7. PubMed ID: 10717619
[TBL] [Abstract][Full Text] [Related]
36. Telomere dynamics in myelodysplastic syndrome determined by telomere measurement of marrow metaphases.
Sashida G; Ohyashiki JH; Nakajima A; Sumi M; Kawakubo K; Tauchi T; Ohyashiki K
Clin Cancer Res; 2003 Apr; 9(4):1489-96. PubMed ID: 12684424
[TBL] [Abstract][Full Text] [Related]
37. Cyclooxygenase-2 (COX-2): first immunohistochemical marker distinguishing early cutaneous melanomas from benign melanocytic skin tumours.
Chwirot BW; Kuźbicki Ł
Melanoma Res; 2007 Jun; 17(3):139-45. PubMed ID: 17505259
[TBL] [Abstract][Full Text] [Related]
38. Nucleolar organizer regions in pigmented skin lesions. Value in the differential diagnosis of Spitz nevi.
González-Cámpora R; Armas-Padrón JR; Rios-Martín JJ; López-Garrido J; Gómez-Pascual A; Galera-Davidson H
Anal Quant Cytol Histol; 1991 Feb; 13(1):16-22. PubMed ID: 1709022
[TBL] [Abstract][Full Text] [Related]
39. Interphase cytogenetics of melanocytic neoplasms: numerical aberrations of chromosomes can be detected in interphase nuclei using centromeric DNA probes.
Matsuta M; Matsuta M; Kon S; Thompson C; LeBoit PE; Weier HU; Gray JW
J Cutan Pathol; 1994 Feb; 21(1):1-6. PubMed ID: 8188929
[TBL] [Abstract][Full Text] [Related]
40. Expression of endoglin in human melanocytic lesions.
Dawn G; MacKie RM
Clin Exp Dermatol; 2002 Mar; 27(2):153-6. PubMed ID: 11952710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
